We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
-1.22%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$526M
AUM Growth
-$4.9M
Cap. Flow
+$3.41M
Cap. Flow %
0.65%
Top 10 Hldgs %
33.37%
Holding
151
New
6
Increased
38
Reduced
84
Closed
10

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.88M
2
MDU icon
MDU Resources
MDU
+$2.59M
3
IBM icon
IBM
IBM
+$2M
4
CMC icon
Commercial Metals
CMC
+$1.84M
5
HPQ icon
HP
HPQ
+$1.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.08%
2 Industrials 22.36%
3 Technology 17.53%
4 Utilities 9.39%
5 Energy 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$646B
$29.5M 5.61%
293,636
+13,315
+5% +$1.35M
GLW icon
2
Corning
GLW
$128B
$22.7M 4.32%
1,001,720
-11,639
-1% -$277K
XOM icon
3
ExxonMobil
XOM
$644B
$22.5M 4.28%
264,840
+32,475
+14% +$2.88M
EMR icon
4
Emerson Electric
EMR
$86.6B
$18M 3.42%
317,933
+9,060
+3% +$527K
KO icon
5
Coca-Cola
KO
$386B
$16.9M 3.2%
415,791
+38,120
+10% +$1.59M
PFE icon
6
Pfizer
PFE
$159B
$14.7M 2.8%
446,303
-5,048
-1% -$160K
PLL
7
DELISTED
PALL CORP
PLL
$14M 2.66%
139,162
-2,490
-2% -$252K
INTC icon
8
Intel
INTC
$473B
$13.1M 2.49%
418,801
-8,350
-2% -$282K
SLB icon
9
SLB Ltd
SLB
$85.1B
$12.2M 2.32%
146,420
+7,825
+6% +$651K
GSK icon
10
GSK
GSK
$102B
$11.9M 2.26%
206,560
+17,656
+9% +$1.01M
MRK icon
11
Merck
MRK
$366B
$11.4M 2.17%
208,268
-4,166
-2% -$236K
BMY icon
12
Bristol-Myers Squibb
BMY
$136B
$10.7M 2.03%
165,469
-57,267
-26% -$3.59M
IBM icon
13
IBM
IBM
$222B
$10.6M 2.01%
69,068
+13,160
+24% +$2M
GVA icon
14
Granite Construction
GVA
$5.44B
$9.65M 1.83%
274,497
+14,620
+6% +$508K
GXP
15
DELISTED
Great Plains Energy Incorporated
GXP
$9.53M 1.81%
357,275
-11,420
-3% -$316K
GE icon
16
GE Aerospace
GE
$355B
$9.5M 1.81%
79,877
+11,643
+17% +$1.39M
BCE icon
17
BCE
BCE
$21.9B
$8.87M 1.68%
209,282
+10,124
+5% +$451K
HON icon
18
Honeywell
HON
$68.9B
$8.7M 1.65%
92,808
-4,275
-4% -$391K
CSCO icon
19
Cisco
CSCO
$433B
$8.24M 1.57%
299,385
-7,250
-2% -$204K
IDA icon
20
Idacorp
IDA
$7.85B
$7.74M 1.47%
123,100
-2,770
-2% -$178K
LNN icon
21
Lindsay Corp
LNN
$1.16B
$7.58M 1.44%
99,388
+14,910
+18% +$1.25M
AZTA icon
22
Azenta
AZTA
$1.44B
$7.16M 1.36%
615,242
-14,850
-2% -$182K
OTTR icon
23
Otter Tail
OTTR
$3.81B
$6.5M 1.24%
201,978
-4,700
-2% -$150K
NVS icon
24
Novartis
NVS
$292B
$5.96M 1.13%
67,506
-1,361
-2% -$121K
NEE icon
25
NextEra Energy
NEE
$171B
$5.83M 1.11%
224,040
-8,600
-4% -$227K

Similar funds

John G. Ullman & Associates's Q1 2015 Portfolio in Review

As of Q1 2015, John G. Ullman & Associates held 151 positions worth $526M, down 0.92% from $531M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q1 2015 filing shows 6 new, 38 increased, 84 reduced and 10 closed positions. Its largest new stake was HP: 103,274 shares worth $1.46M. The largest sale was Medtronic, an estimated $5.19M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q1 2015 buy was HP: 103,274 shares worth $1.46M.
  • John G. Ullman & Associates added most to ExxonMobil in Q1 2015, an estimated $2.88M increase.
  • John G. Ullman & Associates's biggest Q1 2015 reduction was Bristol-Myers Squibb, cutting an estimated $3.59M.
  • John G. Ullman & Associates fully exited Medtronic in Q1 2015, selling an estimated $5.19M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $526M portfolio in Q1 2015.
  • John G. Ullman & Associates opened 6 new positions and closed 10 in Q1 2015.
  • John G. Ullman & Associates's portfolio value fell 0.92% quarter-over-quarter to $526M.

Based on John G. Ullman & Associates's 13F filing for Q1 2015, filed 13 May 2015.